1. Home
  2. MOV vs EOLS Comparison

MOV vs EOLS Comparison

Compare MOV & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Movado Group Inc.

MOV

Movado Group Inc.

HOLD

Current Price

$21.70

Market Cap

416.4M

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$7.14

Market Cap

444.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOV
EOLS
Founded
1961
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
416.4M
444.0M
IPO Year
1993
2018

Fundamental Metrics

Financial Performance
Metric
MOV
EOLS
Price
$21.70
$7.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$31.50
$20.80
AVG Volume (30 Days)
162.2K
1.1M
Earning Date
11-25-2025
11-05-2025
Dividend Yield
6.52%
N/A
EPS Growth
27.72
N/A
EPS
0.97
N/A
Revenue
$661,205,000.00
$285,823,000.00
Revenue This Year
$2.10
$14.36
Revenue Next Year
$0.24
$23.27
P/E Ratio
$22.13
N/A
Revenue Growth
2.78
15.10
52 Week Low
$12.85
$5.71
52 Week High
$21.82
$17.12

Technical Indicators

Market Signals
Indicator
MOV
EOLS
Relative Strength Index (RSI) 65.97 56.75
Support Level $20.39 $6.83
Resistance Level $21.38 $7.29
Average True Range (ATR) 0.66 0.26
MACD 0.06 0.02
Stochastic Oscillator 91.23 88.71

Price Performance

Historical Comparison
MOV
EOLS

About MOV Movado Group Inc.

Movado Group Inc designs, develops, sources, markets, and distributes fine watches in the United States and internationally. It operates through the Watch and Accessory Brands and Company Stores segment. The Watch and Accessory Brands segment includes the designing, manufacturing, and distribution of watches and, to a lesser extent, jewelry and other accessories of quality owned brands and licensed brands. Its Company Stores segment includes the company's retail outlet locations in the United States and Canada. It generates maximum revenue from the Watch and Accessory Brands segment. Geographically, it derives the majority of its revenue from its international locations.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: